Increased Incidence and Risk of Hair Loss with Glucagon-Like Peptide 1 Receptor Agonists: A Real-World Multicenter Cohort Study

October 2025 in “ EMJ Dermatology ”

Yagiz Matthew Akiska, Savanna I Vidal, Nikita Menta, M. Nasseri, Dillon Nussbaum, Colleen Cotton, Leslie Castelo‐Soccio, Adam Friedman

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on emjreviews.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report

December 2024 in “Cureus”

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

research GLP-1 Agonists and Hair Loss: A Call for Further Investigation

May 2024 in “International Journal of Dermatology”

More research is needed to understand if GLP-1 agonists affect hair health.

research Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis

25 citations , February 2022 in “JAAD International”

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

research Association of Type 2 Diabetes With Central-Scalp Hair Loss in a Large Cohort Study of African American Women

16 citations , June 2019 in “International Journal of Women's Dermatology”

Type 2 diabetes may increase the risk of severe hair loss in African American women.